Literature DB >> 6986578

Localization and quantitation of beta-endorphin in human brain and pituitary.

M M Wilkes, W B Watkins, R D Stewart, S S Yen.   

Abstract

The concentration of human beta-endorphin (beta h-EP)) was measured in various hypothalamic nuclei, in extrahypothalamic brain regions and in the anterior and posterior lobes of the pituitary using a specific radioimmunoassay (RIA) The beta h-EP concentrations in the arcuate nucleus (169 +/- 35 pg/100 micrograms protein, n = 7) and median eminence (163 +/- 32 pg/100 micrograms protein, n = 6) were among the highest in the 17 brain areas examined. The immunoreactive beta h-EP in the hypothalamus corresponded to authentic beta h-EP, as determined by gel exclusion chromatography. By chromatography and RIA the beta h-EP concentrations in anterior (1.53 X 10(5) +/- 0.51 X 10(5) pg/100 micrograms protein, n = 3) and posterior (1.41 X 10(5) +/- 0.38 X 10(5) g/100 micrograms protein, n - 5) pituitary were found to be approximately 1,000-fold higher than in hypothalamus. Within the pituitary beta h-EP was localized throughout the anterior lobe, in the pars intermedia and in that part of the posterior lobe nearest the pars intermedia, as judged by immunocytochemistry. Dense immunocytochemical staining was found along the perimeter of many blood vessels. Beta h-EP and adrenocorticotropin (ACTH) were co-localized in the same pituitary cells. The present data represent the first unequivocal localization and quantitation of beta h-EP in human brain and in the separate lobes of the human pituitary.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6986578     DOI: 10.1159/000122985

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

1.  New data on the participation of beta-endorphin in the neuroendocrine control of the release of luteinizing hormone.

Authors:  V N Babichev; I L Kofman
Journal:  Neurosci Behav Physiol       Date:  1982 Nov-Dec

Review 2.  Distribution of beta-endorphin-related peptides in rat pituitary and brain.

Authors:  S Zakarian; D G Smyth
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

3.  Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.

Authors:  G T Griffing; B Berelowitz; M Hudson; R Salzman; J A Manson; S Aurrechia; J C Melby; R C Pedersen; A C Brownie
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

Review 4.  The hypothalamus in Parkinson disease.

Authors:  R Sandyk; R P Iacono; C R Bamford
Journal:  Ital J Neurol Sci       Date:  1987-06

5.  Genetic disruption of gamma-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse.

Authors:  Xi-Ping Ni; David Pearce; Andrew A Butler; Roger D Cone; Michael H Humphreys
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

6.  Presence of beta-endorphin-like immunoreactivity in the anterior pituitary gland of rat and man and evidence for the differential localization with ACTH.

Authors:  W B Watkins; S S Yen; R Y Moore
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

Review 7.  Anorexia nervosa: a unified neurological perspective.

Authors:  Tasneem Fatema Hasan; Hunaid Hasan
Journal:  Int J Med Sci       Date:  2011-10-22       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.